A detailed history of Aviance Capital Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Aviance Capital Partners, LLC holds 88,563 shares of PFE stock, worth $2.37 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
88,563
Previous 89,718 1.29%
Holding current value
$2.37 Million
Previous $2.51 Million 2.11%
% of portfolio
0.35%
Previous 0.37%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$27.7 - $31.39 $31,993 - $36,255
-1,155 Reduced 1.29%
88,563 $2.56 Million
Q2 2024

Aug 09, 2024

SELL
$25.26 - $29.6 $48,903 - $57,305
-1,936 Reduced 2.11%
89,718 $2.51 Million
Q1 2024

Apr 17, 2024

BUY
$25.89 - $29.73 $651,547 - $748,185
25,166 Added 37.85%
91,654 $2.54 Million
Q4 2023

Feb 06, 2024

SELL
$26.13 - $33.94 $59,210 - $76,908
-2,266 Reduced 3.3%
66,488 $1.91 Million
Q3 2023

Nov 06, 2023

SELL
$32.09 - $37.51 $47,204 - $55,177
-1,471 Reduced 2.09%
68,754 $2.28 Million
Q2 2023

Aug 04, 2023

BUY
$36.12 - $41.79 $614 - $710
17 Added 0.02%
70,225 $2.58 Million
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $94,496 - $123,020
2,399 Added 3.54%
70,208 $2.86 Million
Q4 2022

Feb 06, 2023

BUY
$41.75 - $54.5 $30,227 - $39,458
724 Added 1.08%
67,809 $3.48 Million
Q3 2022

Nov 09, 2022

SELL
$43.76 - $53.42 $36,277 - $44,285
-829 Reduced 1.22%
67,085 $2.94 Million
Q2 2022

Aug 08, 2022

BUY
$46.53 - $55.17 $604 - $717
13 Added 0.02%
67,914 $3.56 Million
Q1 2022

May 06, 2022

SELL
$45.75 - $56.69 $13,542 - $16,780
-296 Reduced 0.43%
67,901 $3.52 Million
Q4 2021

Feb 07, 2022

BUY
$41.32 - $61.25 $413 - $612
10 Added 0.01%
68,197 $4.03 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $35,442 - $45,529
903 Added 1.34%
68,187 $2.93 Million
Q2 2021

Aug 06, 2021

SELL
$35.91 - $40.68 $9,695 - $10,983
-270 Reduced 0.4%
67,284 $2.64 Million
Q1 2021

Apr 29, 2021

BUY
$33.49 - $37.77 $13,898 - $15,674
415 Added 0.62%
67,554 $2.45 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $4,585 - $5,830
137 Added 0.2%
67,139 $2.47 Million
Q3 2020

Nov 03, 2020

BUY
$31.75 - $37.25 $1,270 - $1,490
40 Added 0.06%
67,002 $2.46 Million
Q2 2020

Jul 24, 2020

BUY
$30.12 - $36.54 $13,975 - $16,954
464 Added 0.7%
66,962 $2.19 Million
Q1 2020

May 05, 2020

SELL
$27.03 - $38.62 $72,548 - $103,656
-2,684 Reduced 3.88%
66,498 $2.17 Million
Q4 2019

Feb 07, 2020

BUY
$32.92 - $37.36 $28,113 - $31,905
854 Added 1.25%
69,182 $2.71 Million
Q3 2019

Nov 07, 2019

BUY
$32.49 - $42.13 $14,230 - $18,452
438 Added 0.65%
68,328 $2.46 Million
Q2 2019

Aug 12, 2019

SELL
$36.98 - $41.52 $54,582 - $61,283
-1,476 Reduced 2.13%
67,890 $2.94 Million
Q1 2019

May 01, 2019

BUY
$37.5 - $41.2 $7,050 - $7,745
188 Added 0.27%
69,366 $2.95 Million
Q4 2018

Feb 11, 2019

BUY
$38.47 - $43.86 $4,000 - $4,561
104 Added 0.15%
69,178 $3.02 Million
Q3 2018

Nov 09, 2018

BUY
$34.47 - $41.81 $21,647 - $26,256
628 Added 0.92%
69,074 $3.04 Million
Q1 2018

May 03, 2018

SELL
$31.91 - $37.02 $62,958 - $73,040
-1,973 Reduced 2.8%
68,446 $2.43 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $9,645 - $10,234
-290 Reduced 0.41%
70,419 $2.55 Million
Q3 2017

Nov 09, 2017

BUY
$31.0 - $34.15 $2.19 Million - $2.41 Million
70,709
70,709 $2.52 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Aviance Capital Partners, LLC Portfolio

Follow Aviance Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviance Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviance Capital Partners, LLC with notifications on news.